Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Late gains lift Footsie

Mon, 29th Jun 2009 16:50

After a rather sluggish start to the day, Footsie ended with chunky gains, helped by buoyancy on Wall Street. Lloyds Banking topped the list of risers after Goldman Sachs raised its rating on the shares from "neutral" to "buy" and added them to its "conviction buy" list. Goldman Sachs has also lifted its target price from 61p to 107p, after arguing that the market has overdone the doom and gloom for the sector. Barclays, for which Goldman's has a "neutral" rating, and Royal Bank of Scotland, move higher, holding on to Lloyds' coat-tails.Broker coverage also boosted oil firm BG Group, which had its 'outperform' rating re-iterated at Cazenove.And car insurer Admiral was wanted after Credit Suisse upgraded its rating on the stock from "neutral" to "outperform", with an unchanged price target of 1097p.Elsewhere in the financial sector, the generally upward trend of European stock markets today gives a lift to insurers such as Legal & General, Old Mutual and Prudential. Inter-dealer brokers ICAP and Tullett Prebon also get a boost from renewed market optimism. Miners were weak, however, with bid stock Anglo American shifting into reverse before recovering later. Potential merger partner Xstrata ended lower.Outsource giant Serco climbs after it said it remains on track to deliver on its 2009 guidance and continues to see significant opportunities in the current challenging economic environment. Aero-engine developer Rolls-Royce has bought a 33% holding in ODIM, a provider of specialist marine handling systems to the offshore oil and gas industry. Rolls-Royce is paying NOK 700 (£66m) cash to Aker Solutions for 15.5m ordinary shares in ODIM, equivalent to NOK 45 per share.Vodafone edges higher after reports it is poised to buy the T-Mobile business in the UK if it can get it past the regulatory authorities. National Express is another on the up after confirming this morning it has received a bid from rival FirstGroup, which slips back. Hovis to Branston Pickle maker Premier Foods's trading this year has continued on track, with sales of bread especially described as excellent. The heavily indebted group, which raised £379m through a cash call in March, said sales in May and June were in line with the trends in the first four months of 2009. Informa warned that half-year organic revenues at its Events and Training unit will be 'considerably' lower as the group continued to reduce volume to protect profitability in the face of weak demand. Despite this, the high variable cost base will mean that the impact on adjusted operating profit margin will be limited. The share is the best performer among FTSE 350 constituents after Royal Bank of Scotland issued a "buy" recommendation.The stock market recovery since March has boosted the fourth quarter performance of investment management firm Hargreaves Lansdown, which now expects full-year results to be ahead of market expectations. Sector peer Brewin Dolphin moves up in sympathy.Defence group Cobham has landed a big contract to provide communication systems to the US Army. A Cobham-Northrop Grumman team (NGCI) has been selected to provide the VIS-X Vehicular Intercommunication System Expanded for the US Army's Communications and Electronics Command (CECOM). Online fashion retailer Asos produced another year of eye-popping growth, with sales doubling and profits up 93%, though it cautioned its rate of growth could be starting to slow.Sofa and mattress maker Airsprung Furniture is sitting pretty after it returned to profit in the second half of its financial year despite revenues showing little sign of recovery. Titan Europe, which designs and makes undercarriage components for industrial vehicles, said its markets have weakened some more in the second quarter of the company's financial year. The company, which expects to make a loss at the interim stage, said revenue for the first half of 2009 is expected to be around 35% lower than the first half of 2008.Drug developer Alizyme said it is likely to cut a 'significant' number of jobs and may even face going bust if it fails to secure sufficient funding. The group said it does not now expect to have sufficient funding to last beyond the end of August and will be unable to continue as a going concern without the raising of additional funds.Swiss drugs giant Novartis has started a Phase III clinical study of NVA, the treatment it licensed from joint-developers Vectura Group and Sosei Group, triggering milestone payments for both companies.Automated warehousing systems firm SDI is feeling optimistic on the back of an increasing number of contract wins, despite tumbling into the red.FTSE 100 - RisersLloyds Banking Group (LLOY) 70.56p +6.12%Prudential (PRU) 422.75p +5.89%Rio Tinto (RIO) 2,153.00p +4.51%Barclays (BARC) 279.65p +4.31%BG Group (BG.) 1,037.00p +4.12%Schroders (SDR) 846.50p +3.67%Rolls-Royce Group (RR.) 365.75p +3.61%Man Group (EMG) 286.00p +3.53%Old Mutual (OML) 80.69p +3.45%Aviva (AV.) 341.50p +3.41%FTSE 100 - Fallers3i Group (III) 237.50p -2.06%Xstrata (XTA) 672.10p -2.03%Thomas Cook Group (TCG) 199.90p -1.89%British Airways (BAY) 127.50p -1.39%GlaxoSmithKline (GSK) 1,067.50p -1.07%Associated British Foods (ABF) 762.00p -0.91%TUI Travel (TT.) 232.25p -0.85%Marks & Spencer Group (MKS) 309.50p -0.80%Balfour Beatty (BBY) 309.50p -0.64%Pearson (PSON) 605.50p -0.57%FTSE 250 - RisersNational Express Group (NEX) 302.75p +9.79%Informa (INF) 231.00p +9.09%Tullett Prebon (TLPR) 293.25p +8.61%Vectura Group (VEC) 70.50p +8.46%Dunelm (DNLM) 219.50p +6.42%Restaurant Group (RTN) 151.75p +6.30%Morgan Crucible (MGCR) 99.00p +6.17%Brewin Dolphin (BRW) 135.00p +5.88%Moneysupermarket.com (MONY) 51.25p +5.67%Electra Private Equity (ELTA) 945.00p +5.47%FTSE 250 - FallersSThree (STHR) 179.75p -4.77%Punch Taverns (PUB) 105.50p -4.31%DS Smith (SMDS) 67.50p -3.57%Marston's (MARS) 115.25p -2.74%Evolution Group (EVG) 145.00p -2.68%Peter Hambro Mining (POG) 620.00p -2.67%Berkeley Group Holdings Units (BKG) 798.00p -2.27%Northern Foods (NFDS) 54.25p -2.25%Renishaw (RSW) 342.00p -2.15%Ferrexpo (FXPO) 139.00p -2.11%
More News
26 Nov 2018 09:05

Vectura Discontinues VR375 As Phase Three Study Misses Endpoints

LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a

Read more
22 Oct 2018 08:59

Vectura Says New Chief Financial Officer Fry Has Started Week Early

LONDON (Alliance News) - Medical devices developer Vectura Group PLC said Monday Paul Fry will become chief financial officer immediately, rather than from Monday next week.Fry succeeds who

Read more
11 Sep 2018 09:40

Vectura Interim Loss Narrows On Higher Revenue And Lower Expenses

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC on Tuesday said its loss narrowed in the first half of 2018 as it reduced operating costs.Pretax loss narrowed to GBP29.9 in a

Read more
11 Sep 2018 08:18

Vectura's solid interims turn focus further forward

(Sharecast News) - Vectura kept guidance for the full year unchanged as the inhaled medicines specialist reported robust revenue and said it has identified pipeline projects with potential annual sales of over $250m.

Read more
10 Sep 2018 12:49

Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.The company said it expects further launches across to a

Read more
4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 September Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Read more
23 Aug 2018 14:17

Thursday broker round-up

(Sharecast News) - TalkTalk: Barclays upgrades to overweight with a target price of 150p.

Read more
21 Aug 2018 12:31

Vectura concludes two paediatric studies into VR647

(Sharecast News) - Vectura announced the successful conclusion of two paediatric studies to support the potential use of VR647, its wholly-owned drug/device combination asset, on Tuesday.

Read more
21 Aug 2018 09:45

Vectura Group Gets Positive Results From VR647 Phase II Study

LONDON (Alliance News) - Vectura Group PLC said Tuesday that it received positive results form two paediatric studies of its VR647 inhalation system to manage asthma.The two studies, a and

Read more
17 May 2018 10:55

Vectura Group On Track To Achieve Expected Full-Year Revenue

LONDON (Alliance News) - Inhaled product design and development firm Vectura Group PLC said on Thursday based on its trading performance for the year-to-date revenue is currently in line with is a

Read more
11 May 2018 11:35

Nuformix Appoints Former Ventura Chief Executive To Board

LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a

Read more
10 May 2018 16:16

UK Shareholder Meetings Calendar - Next 7 Days

Friday 11 MayBBA AviationMan GroupRSA Insurance GroupJohn Wood Advanced 14 15 Pacific

Read more
24 Apr 2018 13:16

Sosei Group Confirms It Will Not Make Takeover Offer For Vectura

LONDON (Alliance News) - Japanese biotechnology firm Sosei Group Corp said on Tuesday, noting unspecified press reports, it does not intend to make an offer for Vectura Group PLC.Shares in

Read more
23 Apr 2018 09:55

Vectura Adds Ex-GSK And Sanofi Executive Whitaker To Board From June

LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of

Read more
20 Apr 2018 09:59

Vectura CFO Andrew Derodra Leaves To Take Up Role At Unilabs

LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.